Compare WAVE & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAVE | TXMD |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.4M | 25.9M |
| IPO Year | 2021 | 2012 |
| Metric | WAVE | TXMD |
|---|---|---|
| Price | $5.56 | $2.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 8.5K | ★ 27.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.61 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | N/A | $427.09 |
| Revenue Next Year | $400.00 | N/A |
| P/E Ratio | ★ N/A | $90.64 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $4.51 | $0.72 |
| 52 Week High | $9.85 | $2.95 |
| Indicator | WAVE | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 59.97 | 54.29 |
| Support Level | $4.63 | $1.05 |
| Resistance Level | $7.12 | $2.54 |
| Average True Range (ATR) | 0.32 | 0.12 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 87.96 | 74.24 |
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.